Description
HUMATIN MEDICATION
First action · last action
2026-04-08 · 2026-04-29
Transactions
2
First transaction's obligation
$63,000
Base + all options value (sum of deltas)
$63,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25726D0031
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-04-08+$63,000= $63,000
- Mod P000012026-04-29+$0= $63,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-04-08 | +$63,000 | $63,000 | HUMATIN MEDICATION |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2026-04-29 | +$0 | $63,000 | HUMATIN MEDICATION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI L4JDBELFVJ44)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726D0031 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C77025P0114 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $235,013 | FY2025 |
| 36C77025P0046 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $60,143 | FY2025 |
| 36C77025P0036 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $107,136 | FY2025 |
| 36C77024P0337 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $148,800 | FY2024 |
| 36C77024P0326 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $13,781 | FY2024 |
Other recipients under 6505 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0367 | ISORX TEXAS LTD | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $53,945 | FY2026 |
| 36C25726N0407 | CARDINAL HEALTH 414, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,400,000 | FY2026 |
| 36C25726P0476 | PETNET SOLUTIONS, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $40,573 | FY2026 |
| 36C25726P0423 | PANHANDLE NUCLEAR RX, LTD. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $325,038 | FY2026 |
| 36C25726N0316 | PROGENICS PHARMACEUTICALS INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $721,744 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25726N0331_3600_36C25726D0031_3600 · retrieved 2026-09-26.